Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.
about
Elevated risk for HIV-1 infection in adolescents and young adults in São Paulo, BrazilDetection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studiesDemographic profiles of newly acquired HIV infections among adolescents and young adults in the U.S.Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter CohortHigh-accuracy identification of incident HIV-1 infections using a sequence clustering based diversity measure.Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workersSurveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014More and better information to tackle HIV epidemics: towards improved HIV incidence assays.A likelihood estimation of HIV incidence incorporating information on past prevalence.HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy.Evaluation of a multiplex assay for estimation of HIV-1 incidence.Misclassification of recent HIV-1 seroconversion in sub-Saharan Africa using the sensitive/less sensitive technique.Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward.Designing a genome-based HIV incidence assay with high sensitivity and specificity.Modification of AxSYM Human Immunodeficiency Virus Assay to Identify Recent Human Immunodeficiency Virus Infections in Korean Human Immunodeficiency Virus-Positive IndividualsIncidence of recent human immunodeficiency virus infection at two voluntary counseling testing centers in Pernambuco, Brazil, from 2006 to 2009Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 IncidenceDesign of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in IndiaRisk Factor Detection as a Metric of STARHS Performance for HIV Incidence Surveillance Among Female Sex Workers in Kigali, RwandaEstimating the distribution of the window period for recent HIV infections: a comparison of statistical methods.Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation.Current and future assays for identifying recent HIV infections at the population levelEvaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing.Developing high-throughput HIV incidence assay with pyrosequencing platform.Development of a proficiency testing program for the HIV-1 BED incidence assay in ChinaEstimates of HIV-1 incidence based on serological methods: a brief methodological review.Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey.HIV transmission, the Law and the work of the clinical team, January 2013.HIV-1 nonsubtype B distribution across certain resource-rich countries
P2860
Q28471903-73CE97B2-E7DA-45BA-B31B-26E2DDE714D6Q28730904-6E49D342-4E22-4BC7-828C-3643822ECCD5Q33635740-A8253118-8991-4D41-ABF6-B1ADFE79C1E5Q33706522-03612F73-15F7-4A8A-9F3A-054AE4C5CB2BQ33748868-EEA00CE6-9DBF-423A-B6D3-FFB6D07519C8Q33885838-9A848F13-118A-4D4E-A0C8-D8ECDA9B3757Q33892444-ED137374-C518-437E-907A-0E1D89D2D306Q33951907-178A5987-DB8A-4BF9-AFD4-F65DB94E2C3EQ34142137-DB961A4F-A03C-47B9-BB0D-6C538505CB6EQ34203609-9500B3CA-64B1-4E30-9C77-539672CD24D6Q34745421-F49CABC2-6671-418B-A1C0-C8B6E160F128Q34871645-E9DAB4D2-64C6-48DD-A3E5-EA2BB589E48AQ35088760-DE0EF7C1-0750-449A-A201-C66919D68A6EQ35868993-7D977442-91DF-4721-8F0B-8DC130A4278CQ36000117-F21BDBBE-10C4-4C3B-9EAF-FD9F3537C522Q36023003-A4225F2F-5A53-4815-920D-9BBEA85515FFQ36101267-462D4726-ADD7-4B24-BE22-C1CB6B52056FQ36192090-8D8471D5-FD5E-472A-90A9-CA9F65B153F7Q36302106-158F8828-DF17-46FF-8558-8C96E9D56203Q36316124-97211937-DD76-43BA-BB17-6C3FF2AD4FE5Q36414171-EF1C5654-091B-4C26-BB93-866E3BB5BD4BQ36516631-19037091-3460-4852-9C79-E5AB7CD56C68Q37460164-8FCEC39F-7953-4859-89C6-E918061CD2AFQ37613666-8CEF1DBD-E832-4143-9B22-7B2FB4F5A80FQ37643996-A66C7C15-7D1F-4DF5-A4AD-1A05C0EA5D14Q37670395-C099494C-9A60-44C6-BDFA-9D054305CC32Q37866660-CDF9D07C-7648-4851-8B6E-FD6FD9C1B0BAQ38779402-9BBEC6B5-A630-4E1F-A5CA-AA7F48F35758Q40044059-CD3C21FB-9310-4A21-BB80-2767E177DFE5Q40091554-5808D395-E5AD-4F01-A84F-E5FB74D0C8C7Q42200221-6A3DB50F-1312-40D7-8748-597803E1F51AQ42247236-9CD2CF9D-A913-4D5C-8A7A-D77613941F30Q58485636-2852A134-35B3-45A4-A753-EBCDDB9BAAD9
P2860
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Human immunodeficiency virus ( ...... d with diverse HIV-1 subtypes.
@ast
Human immunodeficiency virus ( ...... d with diverse HIV-1 subtypes.
@en
type
label
Human immunodeficiency virus ( ...... d with diverse HIV-1 subtypes.
@ast
Human immunodeficiency virus ( ...... d with diverse HIV-1 subtypes.
@en
prefLabel
Human immunodeficiency virus ( ...... d with diverse HIV-1 subtypes.
@ast
Human immunodeficiency virus ( ...... d with diverse HIV-1 subtypes.
@en
P2093
P2860
P356
P1476
Human immunodeficiency virus ( ...... d with diverse HIV-1 subtypes.
@en
P2093
Donnelly C
Geretti AM
Phillips A
P2860
P304
P356
10.1128/JCM.01879-06
P407
P577
2006-12-06T00:00:00Z